Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2016, Article ID 4792865, 4 pages
http://dx.doi.org/10.1155/2016/4792865
Review Article

Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine

1Department of Plastic and Oral Surgery, Boston Children’s Hospital, Boston, MA 02115, USA
2Harvard Medical School, Program in Global Surgery and Social Change, Boston, MA 02115, USA
3University of Miami Miller School of Medicine, Miami, FL 33136, USA
4Rwanda Military Hospital, Kigali, Rwanda

Received 16 April 2016; Accepted 30 May 2016

Academic Editor: Lei Shi

Copyright © 2016 Allison Silverstein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Singer and A. S. Daar, “Harnessing genomics and biotechnology to improve global health equity,” Science, vol. 294, no. 5540, pp. 87–89, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization, Genomics and World Health: Report of the Advisory Committee on Health Research, World Health Organization, Geneva, Switzerland, 2002.
  3. G. Arpino, D. Generali, A. Sapino et al., “Gene expression profiling in breast cancer: a clinical perspective,” The Breast, vol. 22, no. 2, pp. 109–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Millar, How Personalized Medicine Is Changing: Breast Cancer, Genome, 2014.
  5. C. Sotiriou and L. Pusztai, “Gene-expression signatures in breast cancer,” The New England Journal of Medicine, vol. 360, no. 8, pp. 790–800, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Fitzmaurice, D. Dicker, A. Pain et al., “The global burden of cancer 2013,” JAMA Oncology, vol. 1, pp. 505–527, 2015. View at Google Scholar
  7. P. Farmer, J. Frenk, F. M. Knaul et al., “Expansion of cancer care and control in countries of low and middle income: a call to action,” The Lancet, vol. 376, no. 9747, pp. 1186–1193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. N. Mody, A. Nduaguba, F. Ntirenganya, and R. Riviello, “Characteristics and presentation of patients with breast cancer in Rwanda,” The American Journal of Surgery, vol. 205, no. 4, pp. 409–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. O. Abdulrahman Jr. and G. A. Rahman, “Epidemiology of breast cancer in Europe and Africa,” Journal of Cancer Epidemiology, vol. 2012, Article ID 915610, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. L. A. Oluwagbemiga, A. Oluwole, and A. A. Kayode, “Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in africa?—a systematic review,” SpringerPlus, vol. 1, no. 1, article 83, pp. 1–8, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. D. Reeves, T. M. Yawitch, N. C. van der Merwe, H. J. van den Berg, G. Dreyer, and E. J. van Rensburg, “BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families,” International Journal of Cancer, vol. 110, no. 5, pp. 677–682, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. D. Bustamante, F. M. De La Vega, and E. G. Burchard, “Genomics for the world,” Nature, vol. 475, no. 7355, pp. 163–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. B. Harford, “Barriers to overcome for effective cancer control in Africa,” The Lancet Oncology, vol. 16, no. 8, pp. e385–e393, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Osafo, Y. R. Raji, D. Burke et al., “Human heredity and health (H3) in africa kidney disease research network: a focus on methods in sub-Saharan Africa,” Clinical Journal of the American Society of Nephrology, vol. 10, no. 12, pp. 2279–2287, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. R. E. Ellsworth, D. J. Decewicz, C. D. Shriver, and D. L. Ellsworth, “Breast cancer in the personal genomics era,” Current Genomics, vol. 11, no. 3, pp. 146–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Schoeman, J. P. Apffelstaedt, K. Baatjes, and M. Urban, “Implementation of a breast cancer genetic service in South Africa—lessons learned,” South African Medical Journal, vol. 103, no. 8, pp. 529–533, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Okobia, C. Bunker, J. Zmuda et al., “Case-control study of risk factors for breast cancer in Nigerian women,” International Journal of Cancer, vol. 119, no. 9, pp. 2179–2185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Rosenberg, J. P. Kelly, S. Shapiro, M. Hoffman, and D. Cooper, “Risk factors for breast cancer in South African women,” South African Medical Journal, vol. 92, no. 6, pp. 447–448, 2002. View at Google Scholar · View at Scopus
  19. I. L. Okoronkwo, P. Ejike-Okoye, A. U. Chinweuba, and A. C. Nwaneri, “Financial barriers to utilization of screening and treatment services for breast cancer: an equity analysis in Nigeria,” Nigerian Journal of Clinical Practice, vol. 18, no. 2, pp. 287–291, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. K. M. Schueler, P. W. Chu, and R. Smith-Bindman, “Factors associated with mammography utilization: a systematic quantitative review of the literature,” Journal of Women's Health, vol. 17, no. 9, pp. 1477–1498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. O. Anderson and R. Jakesz, “Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative,” World Journal of Surgery, vol. 32, no. 12, pp. 2578–2585, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. K. Adjei, O. Owusu-Afriyie, B. Awuah, and H. Stalsberg, “Hormone receptors and HER2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway,” The Breast Journal, vol. 20, no. 3, pp. 308–311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. P. A. Bird, A. G. Hill, and N. Houssami, “Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?” Annals of Surgical Oncology, vol. 15, no. 7, pp. 1983–1988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Galukande, H. Wabinga, and F. Mirembe, “Breast cancer survival experiences at a tertiary hospital in sub-Saharan Africa: a cohort study,” World Journal of Surgical Oncology, vol. 13, no. 1, article 220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. B. O. Anderson, R. Shyyan, A. Eniu et al., “Breast cancer in limited-resource countries: an overview of the breast health global initiative 2005 guidelines,” The Breast Journal, vol. 12, no. 1, pp. 3–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Cutuli, C. Lemanski, A. Fourquet et al., “Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience,” British Journal of Cancer, vol. 100, no. 7, pp. 1048–1054, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Dodwell, K. Clements, G. Lawrence et al., “Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project,” British Journal of Cancer, vol. 97, no. 6, pp. 725–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. K. Adesunkanmi, O. O. Lawal, K. A. Adelusola, and M. A. Durosimi, “The severity, outcome and challenges of breast cancer in Nigeria,” The Breast, vol. 15, no. 3, pp. 399–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. E. Kohler, A. Moses, R. Krysiak, N. G. Liomba, and S. Gopal, “Pathologically confirmed breast cancer in Malawi: a descriptive study: clinical profile of breast cancer,” Malawi Medical Journal, vol. 27, no. 1, pp. 10–12, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Sayed, Z. Moloo, R. Wasike et al., “Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya,” The Breast, vol. 23, no. 5, pp. 591–596, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. C. A. Adisa, N. Eleweke, A. Alfred Au et al., “Biology of breast cancer in Nigerian women: a pilot study,” Annals of African Medicine, vol. 11, no. 3, pp. 169–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Ly, M. Antoine, A. K. Dembl et al., “High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital,” Oncology, vol. 83, no. 5, pp. 257–263, 2012. View at Publisher · View at Google Scholar · View at Scopus